OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$891M
1-Year Return
19.89%
This Quarter Return
-20.16%
1 Year Return
+19.89%
3 Year Return
+77.46%
5 Year Return
–
10 Year Return
–
AUM
$1.22B
AUM Growth
+$25.2M
(+2.1%)
Cap. Flow
+$176M
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,483
New
378
Increased
381
Reduced
314
Closed
382
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$6.48M |
| 2 |
Marvell Technology
MRVL
|
+$6.33M |
| 3 |
Zebra Technologies
ZBRA
|
+$6.31M |
| 4 |
Tyler Technologies
TYL
|
+$6.26M |
| 5 |
Walt Disney
DIS
|
+$6.25M |
Top Sells
| 1 |
3M
MMM
|
+$6.39M |
| 2 |
Trade Desk
TTD
|
+$6.28M |
| 3 |
Xylem
XYL
|
+$6.22M |
| 4 |
Gilead Sciences
GILD
|
+$6.21M |
| 5 |
Under Armour
UAA
|
+$6.18M |
Sector Composition
| 1 | Technology | 21.72% |
| 2 | Healthcare | 14.93% |
| 3 | Industrials | 12.39% |
| 4 | Consumer Discretionary | 12.21% |
| 5 | Financials | 11.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOOK
1051
DELISTED
HOOKIPA Pharma
HOOK
| $62K | 0.01% |
3,799
-61
| -2% | -$996 |
|
|
ATNX
1052
DELISTED
Athenex, Inc. Common Stock
ATNX
| $62K | 0.01% |
7,599
| – | – |
|
1053
Lesaka Technologies
LSAK
$372M
| $61K | 0.01% |
11,843
| – | – |
|
1054
Daktronics
DAKT
$856M
| $61K | 0.01% |
20,351
+7,539
| +59% | +$22.6K |
|
1055
Shattuck Labs
STTK
$96.3M
| $60K | ﹤0.01% |
14,862
-10,079
| -40% | -$40.7K |
|
1056
Cadiz
CDZI
$285M
| $59K | ﹤0.01% |
25,371
-14,145
| -36% | -$32.9K |
|
1057
VTEX
VTEX
$741M
| $59K | ﹤0.01% |
+19,191
| New | +$59K |
|
1058
Brilliant Earth
BRLT
$38.1M
| $58K | ﹤0.01% |
+12,278
| New | +$58K |
|
1059
Immuneering
IMRX
$293M
| $57K | ﹤0.01% |
+10,498
| New | +$57K |
|
1060
LiveOne
LVO
$56.9M
| $57K | ﹤0.01% |
66,244
| – | – |
|
1061
FreightCar America
RAIL
$160M
| $56K | ﹤0.01% |
15,486
+2,681
| +21% | +$9.7K |
|
|
VIRX
1062
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $56K | ﹤0.01% |
14,450
-5,155
| -26% | -$20K |
|
|
SIEN
1063
DELISTED
Sientra, Inc.
SIEN
| $55K | ﹤0.01% |
6,610
+4
| +0.1% | +$33 |
|
1064
Pulse Biosciences
PLSE
$1.01B
| $54K | ﹤0.01% |
58,383
+39,981
| +217% | +$37K |
|
1065
Cytosorbents Corp
CTSO
$62.6M
| $53K | ﹤0.01% |
24,367
+6,092
| +33% | +$13.3K |
|
1066
Arq
ARQ
$301M
| $53K | ﹤0.01% |
11,392
-55
| -0.5% | -$256 |
|
|
EVLO
1067
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $53K | ﹤0.01% |
1,267
-44
| -3% | -$1.84K |
|
1068
BeyondSpring
BYSI
$78.2M
| $52K | ﹤0.01% |
36,074
+483
| +1% | +$696 |
|
|
ICAD
1069
DELISTED
iCAD Inc
ICAD
| $52K | ﹤0.01% |
+12,961
| New | +$52K |
|
1070
Tango Therapeutics
TNGX
$759M
| $50K | ﹤0.01% |
+11,075
| New | +$50K |
|
|
ITI
1071
DELISTED
Iteris, Inc.
ITI
| $50K | ﹤0.01% |
17,444
-1,055
| -6% | -$3.02K |
|
1072
Black Diamond Therapeutics
BDTX
$185M
| $49K | ﹤0.01% |
19,807
-7,316
| -27% | -$18.1K |
|
|
KLRS
1073
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.5M
| $48K | ﹤0.01% |
+532
| New | +$48K |
|
1074
KORE Group Holdings
KORE
$39.2M
| $47K | ﹤0.01% |
+3,031
| New | +$47K |
|
|
BCEL
1075
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $47K | ﹤0.01% |
26,313
-2,529
| -9% | -$4.52K |
|